Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Rain
Toggle navigation
Menu
Subscribe
Home
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Zynerba Pharma CS
(NQ:
ZYNE
)
4.270
USD
-0.240 (-5.32%)
Streaming Delayed Price
Updated: 11:01 AM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Zynerba Pharma CS
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference
Today 8:00 EST
From
GlobeNewswire News Releases
Thinking about buying stock in Zomedica, Zynerba Pharmaceuticals, Cronos Group, Hexo Corp, or AzurRx BioPharma?
February 10, 2021
InvestorsObserver issues critical PriceWatch Alerts for ZOM, ZYNE, CRON, HEXO, and AZRX.
From
PR Newswire
Thinking about buying stock in Zomedica, Sundial Growers, Senseonics Holdings, Phunware, or Zynerba Pharmaceuticals?
February 08, 2021
InvestorsObserver issues critical PriceWatch Alerts for ZOM, SNDL, SENS, PHUN, and ZYNE.
From
PR Newswire
Thinking about buying stock in Zomedica, Nokia, Zynerba Pharmaceuticals, Senseonics Holdings, or Atossa Therapeutics?
February 05, 2021
InvestorsObserver issues critical PriceWatch Alerts for ZOM, NOK, ZYNE, SENS, and ATOS.
From
PR Newswire
Thinking about buying stock in Sundial Growers, Sellas Life Sciences, Selecta Biosciences, Outlook Therapeutics, or Zynerba Pharmaceuticals?
February 03, 2021
InvestorsObserver issues critical PriceWatch Alerts for SNDL, SLS, SELB, OTLK, and ZYNE.
From
PR Newswire
Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences
January 04, 2021
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome
December 17, 2020
From
GlobeNewswire News Releases
Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
December 10, 2020
Immunome appoints Richard Baron to BOD and Sandra Stoneman as Chief Legal Officer and Corporate Secretary
From
Business Wire News Releases
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
December 09, 2020
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc. (ZYNE)
From
Business Wire News Releases
The Law Offices of Frank R. Cruz Announces Investigation of Zynerba Pharmaceuticals (ZYNE) on Behalf of Investors
December 07, 2020
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Zynerba Pharmaceuticals (“Zynerba” or the “Company”) (NASDAQ: ZYNE) concerning whether the board...
From
Business Wire News Releases
Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)
December 04, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the 2020 Virtual Annual Meeting of the American Epilepsy Society (AES)
November 23, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
November 09, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th An
October 15, 2020
From
GlobeNewswire News Releases
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Co
October 15, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting
October 08, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Virtual Joint 49th Annual Child Neurology Society & 16th International Child Neurology Society Congress (CNS-ICNA) Meeting
October 08, 2020
From
GlobeNewswire News Releases
Legalization Efforts Continue to Drive the Cannabis Market Growth
September 25, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome
September 17, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals Provides Update on Recent Milestones
September 14, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
September 10, 2020
From
GlobeNewswire News Releases
More People Turn to CBD as its List of Applications Grows
August 14, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
August 10, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
August 06, 2020
From
GlobeNewswire News Releases
Zynerba Pharmaceuticals to Present an Update on the Zygel™ Development Program at the 17th NFXF International Fragile X Conference Research Roundup
July 22, 2020
- New Data Show Statistically Significant Improvements in Caregiver Impression of Change in Fragile X Behaviors Including Social Avoidance in Patients with Fully Methylated FMR1 genes -
From
GlobeNewswire News Releases
Psychedelic Compounds Could be Used in Mental Healthcare
July 15, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Regulators Move to Remove Restriction on Some Uses of Psilocybin
July 06, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Thinking about buying stock in YRC Worldwide, Zynerba Pharmaceuticals, Workhorse Group, Vaxart Inc, or United Airlines?
July 01, 2020
InvestorsObserver issues critical PriceWatch Alerts for YRCW, ZYNE, WKHS, VXRT, and UAL.
From
PR Newswire
Thinking about buying stock in Zomedica Pharmaceuticals, Nio Inc, Advanced Micro Devices, Norwegian Cruise Line, or Zynerba Pharmaceuticals?
June 30, 2020
InvestorsObserver issues critical PriceWatch Alerts for ZOM, NIO, AMD, NCLH, and ZYNE.
From
PR Newswire
Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome
June 30, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.